Greece Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018Document Transcript
Greece Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 67Price: Single User License – US$2500Greece Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, “Greece Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018” provides key market data on the Greece Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Greece Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi , LifeScan, Inc., Novo NordiskA/S , Eli Lilly and Company, Becton, Dickinson and Company and others.
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Greece Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195373-greece-diabetes-care-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 41.2 List of Figures 52 Introduction 72.1 What is This Report About? 73 Diabetes Care Devices In Greece 83.1 Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018 83.2 Diabetes Care Devices, Greece, Company Share (2010-2011) 134 Glucose Monitoring In Greece 154.1 Glucose Monitoring Overall Revenue, (2004-2018) 154.1.1 Blood Glucose Meters, Revenue (2004-2018) 194.2 Glucose Monitoring Overall Volume (2004-2018) 214.2.1 Blood Glucose Meters, Volume (2004-2018) 254.3 Glucose Monitoring Average Price (2004-2018) 274.4 Glucose Monitoring Distribution Share (2010-2011) 284.5 Glucose Monitoring, Greece, Company Share (2010-2011) 295 Insulin Delivery In Greece 315.1 Insulin Delivery Overall Revenue, (2004-2018) 315.1.1 Insulin Pens, Revenue (2004-2018) 355.1.2 Insulin Pumps, Revenue (2004-2018) 395.2 Insulin Delivery Overall Volume (2004-2018) 415.2.1 Insulin Pens, Volume (2004-2018) 455.2.2 Insulin Pumps, Volume (2004-2018) 495.3 Insulin Delivery Average Price (2004-2018) 515.4 Insulin Delivery Distribution Share (2010-2011) 52
5.5 Insulin Delivery, Greece, Company Share (2010-2011) 536 Overview of Key Companies in Greece Diabetes Care Devices Market 556.1 F. Hoffmann-La Roche Ltd. 556.1.1 Company Overview 556.2 Sanofi 556.2.1 Company Overview 556.3 LifeScan, Inc. 566.3.1 Company Overview 566.4 Novo Nordisk A/S 566.4.1 Company Overview 566.5 Eli Lilly and Company 566.5.1 Company Overview 566.6 Bayer HealthCare AG 576.6.1 Company Overview 576.7 Abbott Laboratories 576.7.1 Company Overview 576.8 Becton, Dickinson and Company 586.8.1 Company Overview 586.9 Medtronic, Inc. 586.9.1 Company Overview 586.10 Animas Corporation 596.10.1 Company Overview 596.11 Terumo Corporation 596.11.1 Company Overview 596.12 Ypsomed Holding AG 596.12.1 Company Overview 596.13 Nipro Corporation 606.13.1 Company Overview 607 Appendix 617.1 Global Markets Direct Research Methodology 617.2 Definitions of Markets Covered in the Report 627.2.1 Diabetes Care Devices 627.3 Secondary Research 657.4 Primary Research 657.5 Models 667.6 Forecasts 667.7 Expert Panel Validation 667.8 Currency Conversion 677.9 Contact Us 677.10 Disclaimer 671.1 List of Tables